Phase 3 Clinical Trials Begins for American Company Developed COVID-19 Vaccine
A subject receives a shot in the first-stage safety study clinical trial of a potential vaccine by Moderna for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle, Wash., March 16, 2020. Britain, the United States, and Canada accused Russia on July 16, 2020, of trying to steal information from researchers seeking a COVID-19 vaccine. Ted S. Warren/AP Photo
The third phase of clinical trials for the vaccine developed by Massachusetts-based company, Moderna, has begun, according to a news release issued by the National Institutes of Health (NIH) on Monday, July 27.
This marks the first American company to advance to Phase 3 of clinical testing.
